Clinical Performance of Senofilcon A Investigational Lens

NACompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
Visual Acuity
Interventions
DEVICE

senofilcon A prototype

Test

DEVICE

Dailies Total 1

Control

Trial Locations (19)

13850

Sacco Eye Group, Vestal

24153

Botetourt Eyecare, LLC, Salem

30076

VisualEyes, Roswell

32073

Flora Chen Poveda, OD, PA - Orange Park, Orange Park

32205

Vue Optical Boutique, Jacksonville

32218

Dr. James Weber & Associates, PA - City Square Blvd, Jacksonville

32256

Stam & Associates Eye Care, Jacksonville

32308

Tallahassee Eye Center, Tallahassee

32751

Maitland Vision Center - North Orlando Ave, Maitland

32779

Sabal Eye Care, Longwood

32819

Southwest Orlando Eye Care, Orlando

38111

Optometry Group, LLC, Memphis

38119

Total Eye Care, Memphis

43023

ProCare Vision Centers, Granville

48301

Birmingham Vision Care, Bloomfield

66762

Kannarr Eye Care, Pittsburg

75703

Tyler Eye Associates, Tyler

94110

Randall Go, OD, San Francisco

02888

Dr. David W. Ferris & Associates, Warwick

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY